Shire Pharmaceuticals – Replagal


Replagal is an enzyme replacement therapy for patients with Fabry disease. 

Origin worked with Shire to visually harmonise the Replagal product portfolio.  A global set of packaging, which included over 250 pieces of artwork, was created for use across all countries applying the latest regulatory information. 

We continue to work closely with the regulatory team to ensure updates are applied and that all packaging continues to adapt to the changing regulatory landscape.